Roche Holding AG banner

Intrinsic Value

The intrinsic value of Roche Holding AG (RHHBY) under the Base Case is USD per share. Compared with the current market price of 58.99 USD, the stock appears .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

RHHBY Intrinsic Value

What one share is worth in the bear, base and bull cases.

Create a free account · No card needed

Do our valuations actually work? See backtest results .

Alert me when RHHBY is below its intrinsic value
Today Hidden ·
RHHBY Valuation History

Intrinsic value next to the price over the past 5 years.

Create a free account · No card needed

Alternatives to RHHBY

Fundamental Analysis

What Roche Does

Pharmaceuticals Health Care

Roche Holding AG is a Swiss healthcare company that makes prescription medicines and diagnostic tests. Its drug business focuses on treatments in cancer, immunology, ophthalmology, and other serious diseases, while its diagnostics business sells instruments, lab tests, and software that help hospitals and laboratories detect disease and monitor patients. In simple terms, Roche helps doctors find illnesses and choose treatments, and it earns money by selling these medicines, test kits, and related systems to healthcare providers and distributors.

Headquarters
Switzerland CH
Employees
100 920
IPO date
May 4, 2001
Read the full company overview
View Company Overview

Roche Holding has no economic moat

No Moat Narrow Wide

Roche’s patents protect individual medicines for a time, but lower-priced copies and rival treatments can compete for customers when those protections end or another option is preferred. Patients and prescribers are not tied to Roche’s wider portfolio, and use of its medicines does not make them more valuable simply because more people use them; competitors can challenge Roche product by product.

Read the full moat analysis
Financials

Balance Sheet

Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Latest Earnings Call

Q2 2026 · July 23, 2026

Roche reported broad portfolio and pipeline progress, including notable Diagnostics launches, while management said its full-year outlook remains on track.

Open the earnings call
Stock, day of the call
+1.1%
View Earnings Call

Past 12 months

Continue RHHBY Research

Decided on Roche Holding? Get an email when RHHBY reaches the price you’d buy at. Free with an account.

What is the Intrinsic Value of one RHHBY stock?

The intrinsic value for Roche Holding AG (RHHBY) under the Base Case is USD.

Is RHHBY stock undervalued or overvalued?

Compared with the current market price of 58.99 USD, the stock appears .

How reliable are our estimates? See how past valuations played out
Back to Top